Sep 26

One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks

Add comments

Eli Lilly Canada Inc. is recalling one lot of Glucagon (D239382A, expiry May 10, 2022), following a complaint that a…

Source

Read the full article. Click on the "original post by" author/publication link.


Comments are closed.